In Memoriam: Marjorie (Marj) Joyce, BA

Click Here to Read

Areas of Expertise

Want to learn more about what we do? Take a look at our areas of expertise!


Over the last 9 years, we have helped develop a wide range of educational activities to support optimal outcomes with cancer immunotherapies. With videos, continuing education activities, clinical resources, toolkits, patient decision-support tools, and patient handouts, we have created resources that are making a difference across tumor types in both the United States and internationally.

Click here to learn more about our work in immuno-oncology

Infectious Diseases

Our team has delivered over 100 activities in infectious diseases since 2009. Via close collaboration with the Mycoses Study Group Education & Research Consortium (MSGERC), the Society of Infectious Diseases Pharmacy, the International Society for Human and Animal Mycology, and the Centers for Disease Control and Prevention, we have delivered many impactful activities and resources for health care providers, patients, and caregivers in the United states and internationally.

Click here to learn more about our infectious diseases output.

Health Care Disparities

We are about breaking down barriers to optimal outcomes—including health care disparities. Across our melanoma, immuno-oncology, nonmelanoma skin cancer, and infectious diseases efforts, we have conducted research and developed content on how to break down barriers to optimal outcomes for underserved populations. See our individual therapeutics area pages for the specifics of our important work in this area.

Nonmelanoma Skin Cancer

While nonmelanoma skin cancer (NMSC) is the most common type of cancer, few web resources were available about managing these conditions before was launched. Check out the newly relaunched site, which has reached a community of over 165,000 since 2020.

Click here to learn about what we’ve done so far and where we are going to support the NMSC community.


We have relaunched our content for both melanoma patients and providers, with an eye toward high-impact resources.

Click here to learn more about our resources in melanoma